ACHV
Achieve Life Sciences Inc
7.50$
-3.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.2% | 98.9% | 99.0% | 59.7% | 81.4% | 82.2% | 91.8% | 93.9% | 91.2% | 87.7% | 94.4% | 95.5% | |
| 49.6% | 58.9% | 55.5% | 53.4% | 49.9% | 79.1% | 89.0% | 90.5% | 82.5% | 80.3% | 33.0% | 50.1% | |
| 84.0% | 95.3% | 93.7% | 53.4% | 76.8% | 79.1% | 89.0% | 90.5% | 82.5% | 80.3% | 88.9% | 87.1% | |
| 10.3% | 0.2% | 1.9% | 0.1% | 0.0% | 0.0% | – | 0.3% | 0.4% | 0.6% | – | – | |
| 0.0% | 0.0% | 0.0% | 2.2% | -0.3% | 0.0% | – | – | -8.3% | – | – | – | |
| 0.5% | 1.0% | 0.9% | 0.6% | 0.2% | 0.3% | 0.1% | 0.1% | 0.4% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 10.5% | 5.4% | 4.9% | 2.6% | 2.2% | 3.5% | 5.3% | 2.7% | 2.5% | |
| 0.0% | 0.0% | 0.0% | 25.6% | 12.1% | 9.9% | 4.6% | 3.5% | 4.7% | 6.2% | 2.5% | 1.8% | |
| 39.5% | 35.7% | 31.0% | 20.3% | 17.2% | 14.4% | 7.5% | 41.0% | 72.3% | 107.5% | 45.9% | 48.5% | |
| 39.5% | 35.5% | 30.8% | 20.3% | 17.1% | 13.6% | 7.3% | 9.6% | 72.1% | 107.4% | 17.3% | 21.7% | |
| 0.8% | 0.1% | 3.2% | 0.3% | 0.1% | 1.0% | 0.2% | 0.1% | 53.8% | 86.3% | 0.1% | 9.0% | |
| 0.1% | 2.3% | 7.7% | 2.2% | 0.8% | 4.1% | 0.8% | 1.8% | 5.5% | 3.2% | 5.0% | 2.1% | |
| 0.0% | 0.2% | 0.2% | 0.0% | – | – | – | 31.4% | 53.6% | – | 25.5% | 26.8% | |
| 60.5% | 64.3% | 69.0% | 79.7% | 82.8% | 85.6% | 92.5% | 59.0% | 27.7% | -7.5% | 54.1% | 51.5% | |
| -284.2% | -303.8% | -716.9% | -128.3% | -133.0% | -216.8% | -150.0% | -197.0% | -453.6% | -855.7% | -532.1% | -622.7% | |
| 0.0% | 0.0% | 0.0% | 0.2% | 0.9% | 2.0% | 6.7% | 17.1% | 35.3% | 102.4% | 83.0% | 104.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.